Dr. Gary Small answers the question: 'MRI, PET Scan for Alzheimer's Diagnosis?' May 4, 2009 -- Question: When are imaging diagnostics, such as an MRI or PET scan, used to determine whether I have ...

NEW ORLEANS (June 23, 2025)—A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of speech (PAOS), a rare neurodegenerative disorder ...

A response-adapted approach to the treatment of patients with advanced Hodgkin's lymphoma de-escalates treatment after an early negative PET scan and intensifies treatment in those with a PET-positive ...

The FDA has approved an updated label for Vizamyl (flutemetamol F 18 injection), including quantification which enables a more continuous and objective measure of amyloid in the brain This approval ...

Assessment of clinical utility and microsatellite instability detection on the Marsden360 ctDNA sequencing panel. Preclinical evaluation of 64Cu-labeled cetuximab in immuno-PET for detecting sentinel ...

A positron emission tomography (PET) scan is a diagnostic tool that examines body tissue functioning, such as blood flow, oxygen use, and sugar metabolism, to help doctors diagnose and treat disease.

The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is the first blood test aiding Alzheimer's diagnosis by detecting amyloid plaques, offering a less invasive alternative to PET scans. The test ...